ProfileGDS5678 / 1427806_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 30% 30% 30% 30% 30% 36% 39% 30% 30% 30% 30% 30% 30% 30% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.7063630
GSM967853U87-EV human glioblastoma xenograft - Control 22.6800630
GSM967854U87-EV human glioblastoma xenograft - Control 32.6859530
GSM967855U87-EV human glioblastoma xenograft - Control 42.6225430
GSM967856U87-EV human glioblastoma xenograft - Control 52.6285830
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.8892936
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.9568839
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.6669930
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.6623630
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.6678130
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.6746430
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.6463730
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.6774330
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.6808530